02.04.2012 09:30
Bewerten
(0)

Illumina Announces Preliminary Revenue for First Quarter 2012

DRUCKEN

Illumina, Inc. (NASDAQ:ILMN) today announced estimated first quarter revenue of approximately $270 million. This number is based on a preliminary estimate and remains subject to review by Illumina’s independent registered public accounting firm. Analysis of the remainder of the income statement is incomplete, but the company expects non-GAAP EPS to be at or above current consensus estimates. Full quarterly results will be announced later this month.

"We are very pleased with our preliminary revenue results and the ability of the company to focus and execute this quarter. This is our third consecutive quarter with a book-to-bill over 1, and we are very encouraged by evidence that our customers are getting back to work," said Jay Flatley, President & CEO of Illumina. "Our annualized HiSeq consumable pull-through grew to approximately $300,000 per instrument in Q1, a very encouraging trend."

Use of forward-looking statements

This release contains projections, information about our financial outlook, earnings guidance, and other forward-looking statements that involve risks and uncertainties. These forward-looking statements are based on our expectations as of the date of this release and may differ materially from actual future events or results. Among the important factors that could cause actual results to differ materially from those in any forward-looking statements are (i) our ability to develop and commercialize further our sequencing, array, PCR, and consumables technologies and to deploy new products and applications, and expand the markets, for our technology platforms; (ii) our ability to manufacture robust instrumentation and consumables; (iii) our expectations and beliefs regarding future conduct and growth of the business and the markets in which we operate; (iv) challenges inherent in developing, manufacturing, and launching new products and services; (v) business disruptions associated with the tender offer commenced by CKH Acquisition Corporation, a wholly owned subsidiary of Roche Holding Ltd; (vi) our ability to maintain our revenue and profitability during periods of research funding reduction or uncertainty and adverse economic and business conditions, including as a result of slowing economic growth in the United States or worldwide, together with other factors detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We undertake no obligation, and do not intend, to update these forward-looking statements, to review or confirm analysts’ expectations, or to provide interim reports or updates on the progress of the current financial quarter.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

ADDITIONAL INFORMATION AND WHERE TO FIND IT

This communication does not constitute an offer to buy or a solicitation of an offer to sell any securities. In response to the tender offer commenced by CKH Acquisition Corporation, a wholly owned subsidiary of Roche Holding Ltd, Illumina has filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC. INVESTORS AND SECURITY HOLDERS OF ILLUMINA ARE URGED TO READ THE SOLICITATION/RECOMMENDATION STATEMENT AND OTHER DOCUMENTS FILED WITH THE SEC (WHEN THEY BECOME AVAILABLE) CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Investors and security holders are able to obtain free copies of these documents and other documents filed with the SEC by Illumina (when they become available) through the web site maintained by the SEC at http://www.sec.gov. Investors and security holders also are able to obtain free copies of these documents, and other documents filed with the SEC by Illumina (when they become available), from Illumina by directing a request to Illumina, Inc., Attn: Investor Relations, Kevin Williams, MD, kwilliams@illumina.com.

In addition, in connection with its 2012 Annual Meeting of Stockholders, Illumina has filed a definitive proxy statement and a WHITE proxy card with the SEC on March 19, 2012, and has mailed the definitive proxy statement and WHITE proxy card to its security holders. INVESTORS AND SECURITY HOLDERS OF ILLUMINA ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND THE WHITE PROXY CARD FOR THE 2012 ANNUAL MEETING OF STOCKHOLDERS AND OTHER DOCUMENTS FILED WITH THE SEC (WHEN THEY BECOME AVAILABLE) CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Investors and security holders are able to obtain free copies of the definitive proxy statement and other documents filed with the SEC by Illumina (when they become available) through the web site maintained by the SEC at http://www.sec.gov. Investors and security holders also are able to obtain free copies of the definitive proxy statement, and other documents filed with the SEC by Illumina (when they become available), from Illumina by directing a request to Illumina, Inc., Attn: Investor Relations, Kevin Williams, MD, kwilliams@illumina.com.

CERTAIN INFORMATION REGARDING PARTICIPANTS IN THE SOLICITATION

Illumina and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies in connection with Illumina’s 2012 Annual Meeting of Stockholders under the rules of the SEC. Security holders may obtain information regarding the names, affiliations and direct and indirect interests (by security holdings or otherwise) of Illumina’s directors and executive officers in (i) Illumina’s Annual Report on Form 10-K for the year ended January 1, 2012, which was filed with the SEC on February 24, 2012, and (ii) Illumina’s definitive proxy statement for its 2012 Annual Meeting of Stockholders, which was filed with the SEC on March 19, 2012. To the extent that Illumina’s directors’ and executive officers’ holdings of Illumina’s securities have changed from the amounts printed in the definitive proxy statement for the 2012 Annual Meeting of Stockholders, such changes have been or will be reflected on Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

Nachrichten zu Illumina Inc.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Illumina Inc.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
07.08.2017Illumina BuyCanaccord Adams
02.08.2017Illumina Equal-WeightFirst Analysis Securities
26.04.2017Illumina NeutralCantor Fitzgerald
01.02.2017Illumina BuyUBS AG
18.01.2017Illumina HoldDeutsche Bank AG
07.08.2017Illumina BuyCanaccord Adams
01.02.2017Illumina BuyUBS AG
04.05.2016Illumina BuyStifel, Nicolaus & Co., Inc.
03.05.2016Illumina BuyUBS AG
21.12.2015Illumina BuyStifel, Nicolaus & Co., Inc.
02.08.2017Illumina Equal-WeightFirst Analysis Securities
26.04.2017Illumina NeutralCantor Fitzgerald
18.01.2017Illumina HoldDeutsche Bank AG
11.10.2016Illumina HoldCanaccord Adams
11.10.2016Illumina HoldCantor Fitzgerald
02.11.2016Illumina UnderweightFirst Analysis Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Illumina Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Vier Gewinneraktien der Autorevolution

Auf der diesjährigen IAA in Frankfurt wurde deutlich: Die Elektromobilität ist nicht mehr aufzuhalten. Alle großen Automobilhersteller stellen ihre Produktionslinien um. Im neuen Anlegermagazin lesen Sie, welche vier Aktien durch autonomes Fahren und Elektromobilität auf der Gewinnerseite stehen könnten.
Anlegermagazin kostenlos erhalten

Illumina Peer Group News

Keine Nachrichten gefunden.

Heute im Fokus

DAX schließt mit Verlust -- Dow kaum bewegt -- Warum die Bitcoin Group-Aktie weiter steigt -- SAP hebt Ausblick an -- Varta-IPO: Börsengang erfolgreich -- eBay, American Express, Unilever im Fokus

Über Alphabet-Fonds: Uber-Rivale Lyft sammelt weitere Milliarde ein. Richter befasst sich mit möglicherweise unerlaubten Geschäften Trumps. Wirbelstürme zerfleddern Gewinn von US-Versicherer Travelers. Air Berlin: Bund fordert Lufthansa-Engagement in Transfergesellschaft.

Top-Rankings

KW 41: Analysten-Flops der Woche
Diese Aktien stehen auf den Verkauflisten der Experten
KW 41: Analysten-Tops der Woche
Diese Aktien stehen auf den Kauflisten der Experten
Siebenstelliges Jahresgehalt
In diesen Bundesländern leben die Bestverdiener

Umfrage

Die CDU hat rund zwei Prozentpunkte bei der Niedersachsen-Wahl verloren. Nun fordern Konservative Merkels Rücktritt. Was halten Sie davon?

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
BYD Co. Ltd.A0M4W9
Daimler AG710000
Varta AGA0TGJ5
Deutsche Bank AG514000
Volkswagen (VW) AG Vz.766403
GeelyA0CACX
Millennial Lithium CorpA2AMUE
Bitcoin Group SEA1TNV9
Apple Inc.865985
CommerzbankCBK100
EVOTEC AG566480
SAP SE716460
Infineon AG623100
Amazon906866
E.ON SEENAG99